Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing DNA vaccines that call to dendritic cells.

Michele A Kutzler1, David B Weiner

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

The Journal of Clinical Investigation
|November 3, 2004
PubMed
Summary

Enhancing DNA vaccines involves co-administering plasmids encoding macrophage inflammatory protein-1alpha (MIP-1alpha) and fms-like tyrosine kinase 3 ligand (Flt3L) with the vaccine. This approach boosts dendritic cell (DC) activity, improving immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Adenosine as a metabolic checkpoint in CD8+ T cell dysfunction.

Trends in immunology·2026
Same author

Adenosine deaminase co-immunization reverses age-associated immunosenescence by restoring germinal center T follicular helper cell function.

bioRxiv : the preprint server for biology·2026
Same author

Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretins.

Trends in biotechnology·2026
Same author

Early immune events during SARS-CoV-2 infection impact memory T and B cell responses.

Communications biology·2026
Same author

Efficient in vivo assembly of DNA encoded polyvalent BTEs for dual antigen targeting for broadening therapeutic impact in ovarian cancer.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • DNA vaccination shows promise but faces challenges in immunogenicity, particularly in humans.
  • Antigen-presenting cells (APCs), especially dendritic cells (DCs), are crucial for effective vaccine antigen presentation.
  • Current DNA vaccine strategies require enhancement to improve their potency and efficacy.

Discussion:

  • This study investigates a novel strategy to enhance DNA vaccine potency by targeting APCs, specifically DCs.
  • The research explores the synergistic effects of co-delivering vaccine plasmids with those encoding MIP-1alpha and Flt3L.
  • The focus is on improving the recruitment, expansion, and activation of DCs in vivo.

Key Insights:

  • Co-vaccination with MIP-1alpha and Flt3L plasmids synergistically enhances DC recruitment, expansion, and activation in vivo.

Related Experiment Videos

  • This combined approach significantly improves cellular immunity, evidenced by enhanced tetramer responses.
  • Increased IFN-gamma secretion by antigen-specific cells indicates a more robust immune response.

    • Outlook:

    • This strategy offers a simple, single-platform approach for developing more potent DNA vaccines.
    • Further research may explore the application of this method in nonhuman primates and humans to overcome current immunogenicity limitations.
    • The findings pave the way for improved vaccine and immune therapeutic development.